6.70
price down icon0.89%   -0.06
pre-market  시장 영업 전:  6.71   0.010   +0.15%
loading
전일 마감가:
$6.76
열려 있는:
$6.72
하루 거래량:
717.76K
Relative Volume:
0.42
시가총액:
$360.64M
수익:
$217.25M
순이익/손실:
$-50.92M
주가수익비율:
-6.70
EPS:
-1
순현금흐름:
$-100.85M
1주 성능:
+3.55%
1개월 성능:
+10.38%
6개월 성능:
-57.11%
1년 성능:
-72.05%
1일 변동 폭
Value
$6.54
$6.758
1주일 범위
Value
$6.24
$6.84
52주 변동 폭
Value
$4.32
$25.42

Prothena Corporation Plc Stock (PRTA) Company Profile

Name
명칭
Prothena Corporation Plc
Name
전화
011-353-1-236-2500
Name
주소
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Name
직원
163
Name
트위터
@ProthenaCorp
Name
다음 수익 날짜
2025-02-18
Name
최신 SEC 제출 서류
Name
PRTA's Discussions on Twitter

PRTA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PRTA
Prothena Corporation Plc
6.70 363.87M 217.25M -50.92M -100.85M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-28 다운그레이드 BofA Securities Neutral → Underperform
2025-05-27 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2025-05-27 다운그레이드 Jefferies Buy → Hold
2025-05-27 다운그레이드 Oppenheimer Outperform → Perform
2024-12-20 개시 Chardan Capital Markets Buy
2024-01-30 다운그레이드 BofA Securities Buy → Neutral
2023-12-12 개시 Deutsche Bank Buy
2023-04-24 개시 SVB Securities Outperform
2023-01-27 개시 Piper Sandler Overweight
2022-11-04 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2022-09-28 업그레이드 BofA Securities Neutral → Buy
2021-11-19 개시 JMP Securities Mkt Outperform
2021-06-18 업그레이드 BofA Securities Underperform → Neutral
2021-06-08 재확인 Oppenheimer Outperform
2021-05-26 개시 Citigroup Buy
2021-02-26 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2021-02-12 업그레이드 Jefferies Hold → Buy
2021-02-02 업그레이드 BTIG Research Neutral → Buy
2020-12-07 개시 H.C. Wainwright Buy
2020-07-09 업그레이드 Oppenheimer Perform → Outperform
2019-11-19 업그레이드 Evercore ISI In-line → Outperform
2018-05-21 다운그레이드 Barclays Equal Weight → Underweight
2018-04-23 다운그레이드 Jefferies Buy → Hold
2018-04-05 재확인 Barclays Overweight
2017-11-20 다운그레이드 Wedbush Outperform → Neutral
2017-09-29 재확인 BTIG Research Buy
2017-09-15 개시 RBC Capital Mkts Outperform
2017-08-17 개시 Evercore ISI Outperform
2017-07-11 개시 Jefferies Buy
2017-04-12 개시 Cantor Fitzgerald Overweight
2017-04-12 개시 Piper Jaffray Overweight
2017-03-02 개시 Instinet Buy
2016-12-21 개시 SunTrust Buy
2016-11-03 개시 Deutsche Bank Buy
2016-08-04 재확인 Barclays Overweight
2016-05-13 개시 Barclays Overweight
2016-02-19 재확인 Wedbush Outperform
2016-01-21 개시 Credit Suisse Outperform
모두보기

Prothena Corporation Plc 주식(PRTA)의 최신 뉴스

pulisher
Jul 24, 2025

What analysts say about Prothena Corporation plc stockFree AI-Backed Trading Signals - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Prothena Corporation plc stock priceFree Stock Market Real-Time Monitoring - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

Is Prothena Corporation plc a good long term investmentHigh-velocity gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Prothena Corporation plc (NASDAQ:PRTA) Receives $31.50 Average Price Target from Analysts - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

Prothena Corporation plc Stock Analysis and ForecastFree Stock Market Forecast Reports - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 17, 2025

How to Take Advantage of moves in (PRTA) - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 15, 2025

Why Prothena Corporation plc stock attracts strong analyst attentionFree Smart Investment Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Prothena Corporation plc stock price move sharplyFree Stock Market Practical Discussion Forums - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Prothena Corporation plc stock performs during market volatilityFree Capital Allocation Plans - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Cambridge Investment Research Advisors Inc. Acquires Shares of 10,164 Prothena Corporation plc (NASDAQ:PRTA) - Defense World

Jul 15, 2025
pulisher
Jul 14, 2025

Piper Sandler Reduces Prothena (PRTA) Price Target to $81 from $110 Following AFFIRM-AL Trial Discontinuation - MSN

Jul 14, 2025
pulisher
Jul 04, 2025

PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects? - sharewise.com

Jul 04, 2025
pulisher
Jul 04, 2025

Roche’s Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA) - MSN

Jul 04, 2025
pulisher
Jun 20, 2025

Prothena to lay off majority of staff; Zealand shares obesity drug data - BioPharma Dive

Jun 20, 2025
pulisher
Jun 19, 2025

Peninsula biotech will cut half its workforce, but partner takes Parkinson's drug into late-stage trial - The Business Journals

Jun 19, 2025
pulisher
Jun 18, 2025

Prothena announces 63% workforce reduction following birtamimab halt - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena (PRTA) Cuts Workforce by 63% to Reduce Costs - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena (PRTA) Shares Rise Following Corporate Restructuring an - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena Announces Major Workforce Reduction to Cut Costs - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena (PRTA) Adjusts 2025 Financial Outlook Amid Reorganizati - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena Announces Corporate Restructuring | PRTA Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena (PRTA) Announces Leadership Changes Amid Workforce Reduction | PRTA Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena to cut workforce by 63% amid strategic review - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena announces corporate restructuring - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena Announces Corporate Restructuring - Business Wire

Jun 18, 2025
pulisher
Jun 18, 2025

Chardan Lowers Prothena (PRTA) Price Target Following AFFIRM-AL Trial Failure - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Prothena (NASDAQ:PRTA) Shares Pass Below 200 Day Moving Average – Time to Sell? - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Roche And Prothena: Why Moving On Makes Sense (OTCMKTS:RHHBY) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 16, 2025

(PRTA) Trading Signals - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 16, 2025

Financial Analysis: Prothena Corporation plc (PRTA)’s Ratios Unveil Key Insights - DWinneX

Jun 16, 2025
pulisher
Jun 16, 2025

Prothena stock rises on Parkinson's trial update (PRTA:NASDAQ) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

Prothena’s Prasinezumab Advances to Phase III for Parkinson’s - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Prothena partner Roche advances Parkinson’s drug to phase 3 By Investing.com - Investing.com Nigeria

Jun 16, 2025
pulisher
Jun 16, 2025

Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease - BioSpace

Jun 16, 2025
pulisher
Jun 16, 2025

Prothena's Partner to Advance Potential Parkinson's Treatment to Phase 3 Development - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Prothena's Partner Roche to Advance Prasinezumab into Phase III - GuruFocus

Jun 16, 2025

Prothena Corporation Plc (PRTA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Prothena Corporation Plc 주식 (PRTA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
EcoR1 Capital, LLC
10% Owner
May 06 '25
Sale
7.64
1,984,053
15,164,712
5,304,596
EcoR1 Capital, LLC
10% Owner
May 05 '25
Sale
8.11
977,693
7,930,166
7,288,649
SCULLY WILLIAM P
10% Owner
Jan 14 '25
Buy
12.79
100,000
1,279,040
735,993
SCULLY WILLIAM P
10% Owner
Dec 18 '24
Buy
13.93
73,436
1,022,670
1,297,693
SCULLY WILLIAM P
10% Owner
Dec 31 '24
Buy
13.01
32,000
416,393
650,193
SCULLY WILLIAM P
10% Owner
Dec 20 '24
Buy
15.91
2,000
31,813
618,693
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
자본화:     |  볼륨(24시간):